Cargando…
The Ghrelin/Growth Hormone Secretagogue Receptor System Is Involved in the Rapid and Sustained Antidepressant-Like Effect of Paeoniflorin
Major depressive disorder (MDD) is a debilitating mental illness affecting people worldwide. Although significant progress has been made in the development of therapeutic agents to treat this condition, fewer than half of all patients respond to currently available antidepressants, highlighting the...
Autores principales: | Zhang, Yuan, Zhu, Min-Zhen, Qin, Xi-He, Zeng, Yuan-Ning, Zhu, Xin-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920966/ https://www.ncbi.nlm.nih.gov/pubmed/33664648 http://dx.doi.org/10.3389/fnins.2021.631424 |
Ejemplares similares
-
Neuroprotective Actions of Ghrelin and Growth Hormone Secretagogues
por: Frago, Laura M., et al.
Publicado: (2011) -
Is ghrelin a glucagon‐like peptide‐1 secretagogue?
por: Ueno, Hiroaki, et al.
Publicado: (2015) -
The antidepressant-like effects of paeoniflorin in mouse models
por: QIU, FENGMEI, et al.
Publicado: (2013) -
Diversification and coevolution of the ghrelin/growth hormone secretagogue receptor system in vertebrates
por: Tine, Mbaye, et al.
Publicado: (2016) -
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
por: Shankar, Kripa, et al.
Publicado: (2021)